About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

SANTEN PHARMACEUTICAL CO.,LTD.(4536) Summary

4536
TSE Prime
SANTEN PHARMACEUTICAL CO.,LTD.
1,404.5
JPY
+27.0
(+1.96%)
Apr 10, 3:30 pm JST
9.56
USD
Apr 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
14.7
PBR
1.69
Yield
2.56%
Margin Trading Ratio
18.85
Stock Price
Apr 10, 2025
Opening Apr 10, 9:00 am
1,389.0 JPY 9.42 USD
Previous Close Apr 9
1,377.5 JPY 9.47 USD
High Apr 10, 3:15 pm
1,408.5 JPY 9.60 USD
Low Apr 10, 9:09 am
1,364.5 JPY 9.26 USD
Volume
1,820,600
Trading Value
2.54B JPY 0.02B USD
VWAP
1396.17 JPY 9.52 USD
Minimum Trading Value
140,450 JPY 956 USD
Market Cap
0.48T JPY 3.29B USD
Number of Trades
5,027
Liquidity & Number of Trades
As of Apr 10, 2025
Liquidity
High
1-Year Average
2,830
1-Year High Aug 6, 2024
10,174
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 61,300 395,500 6.45
Mar 28, 2025 62,900 465,500 7.40
Mar 21, 2025 60,200 472,000 7.84
Mar 14, 2025 59,700 432,700 7.25
Mar 7, 2025 62,900 396,100 6.30
Company Profile
SANTEN PHARMACEUTICAL CO., LTD. is a leading manufacturer of ophthalmic pharmaceuticals. Its flagship product is the over-the-counter eye drop brand "Sante". The company is strengthening its global expansion.
Sector
Pharmaceuticals
SANTEN PHARMACEUTICAL CO., LTD. primarily focuses on prescription pharmaceuticals, while also engaging in the research, development, manufacturing, and sales of over-the-counter drugs and medical devices. The company specializes in ophthalmology products. It operates globally, with a presence in Japan, China, Asia, Europe, the Middle East, Africa, North America, and other regions worldwide, forming a global corporate group. The overseas sales ratio accounts for approximately 40% of total revenue. The group consists of SANTEN PHARMACEUTICAL CO., LTD., 34 consolidated subsidiaries, and 2 equity-method affiliates. With numerous subsidiaries across the globe, the group implements business strategies tailored to the market characteristics of each region.